NCT04308252View on ClinicalTrials.gov

Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 15, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

March 15, 2022

Conditions
Epilepsy in ChildrenPharmaco-Resistant Epilepsy
Trial Locations (1)

02116

Boston Children's Hospital, Boston

Sponsors

Lead Sponsor

Senda Biosciences
All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

lead

Senda Biosciences

INDUSTRY

NCT04308252 - Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy | Biotech Hunter | Biotech Hunter